| Katie L Scott, APNP | |
|
721 American Ave Ste 310, Waukesha, WI 53188-5071 | |
| (262) 928-5900 | |
| Not Available |
| Full Name | Katie L Scott |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 721 American Ave Ste 310, Waukesha, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023574555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 8838 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prohealth Medical Group Inc | 3476465188 | 417 |
News Archive
Ultrasound technology has evolved dramatically in recent years. A group of noted obstetricians and gynecologists maintain that ultrasound is more cost-effective and safer than other imaging modalities for imaging the female pelvis and should be the first imaging modality used for patients with pelvic symptoms.
Promoting the signaling pathway of reelin -an essential extracellular protein for the neuronal migration and synaptic plasticity- could be an effective therapeutical strategy to counterbalance the main cognitive, biochemical and behavioral alterations seen in Alzheimer's and other pathologies associated with Tau protein, as shown in a new study with animal models -published in the journal Progress in Neurobiology.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and nine-month periods ended September 30, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.7% and 53.0%, respectively, over the three-month period ended September 30, 2008.
Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research team led by Paolo Macchiarini, MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by HART.
Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.
› Verified 9 days ago
| Entity Name | Prohealth Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
Ultrasound technology has evolved dramatically in recent years. A group of noted obstetricians and gynecologists maintain that ultrasound is more cost-effective and safer than other imaging modalities for imaging the female pelvis and should be the first imaging modality used for patients with pelvic symptoms.
Promoting the signaling pathway of reelin -an essential extracellular protein for the neuronal migration and synaptic plasticity- could be an effective therapeutical strategy to counterbalance the main cognitive, biochemical and behavioral alterations seen in Alzheimer's and other pathologies associated with Tau protein, as shown in a new study with animal models -published in the journal Progress in Neurobiology.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and nine-month periods ended September 30, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.7% and 53.0%, respectively, over the three-month period ended September 30, 2008.
Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research team led by Paolo Macchiarini, MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by HART.
Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie L Scott, APNP 721 American Ave Ste 310, Waukesha, WI 53188-5071 Ph: (262) 928-5900 | Katie L Scott, APNP 721 American Ave Ste 310, Waukesha, WI 53188-5071 Ph: (262) 928-5900 |
News Archive
Ultrasound technology has evolved dramatically in recent years. A group of noted obstetricians and gynecologists maintain that ultrasound is more cost-effective and safer than other imaging modalities for imaging the female pelvis and should be the first imaging modality used for patients with pelvic symptoms.
Promoting the signaling pathway of reelin -an essential extracellular protein for the neuronal migration and synaptic plasticity- could be an effective therapeutical strategy to counterbalance the main cognitive, biochemical and behavioral alterations seen in Alzheimer's and other pathologies associated with Tau protein, as shown in a new study with animal models -published in the journal Progress in Neurobiology.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and nine-month periods ended September 30, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.7% and 53.0%, respectively, over the three-month period ended September 30, 2008.
Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research team led by Paolo Macchiarini, MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by HART.
Novo Nordisk today announced that the Food and Drug Administration (FDA) has approved the new drug application (NDA) for Saxenda® (liraglutide [rDNA origin] injection), the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.
› Verified 9 days ago
Mr. Carla L Foley, MSN FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20611 Watertown Rd, Waukesha, WI 53186 Phone: 262-798-1910 | |
Annette Quinn, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 725 American Ave, Prohealth Care Women's Center, Waukesha, WI 53188 Phone: 262-928-3500 | |
Renelle L Staus, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W231n1440 Corporate Ct, Waukesha, WI 53186 Phone: 262-896-6000 | |
Ms. Danielle Marie Bernacchi, MSN, FNP-C, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: W308s2809 Wild Berry Ct, Waukesha, WI 53188 Phone: 262-391-0575 | |
Miss Amelia Tollefson, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1130 W Sunset Dr, Waukesha, WI 53189 Phone: 866-389-2727 | |
Kaitlyn Solveson, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2428 N Grandview Blvd Ste 102, Waukesha, WI 53188 Phone: 877-307-3226 Fax: 866-384-9486 |